Exploring the role of adjuvant chemotherapy in older patients with early-stage pancreatic adenocarcinoma.
INTRODUCTION The survival advantage of adjuvant chemotherapy (AC) for older patients with stage I pancreatic ductal adenocarcinoma (PDAC) is unclear, yet it is a mainstay of treatment. This study aims to explore the association of AC with overall survival (OS) in patients of various age groups. MATERIALS AND METHODS...